Germany
Japan
United Kingdom
China
Primary Antibodies
View as table Download
Goat Anti-Neurofascin / NFASC (aa877-890) Antibody
| Applications | WB |
| Reactivities | Human, Rat |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-NFSPNQTKFTVQRT, from the internal region of the protein sequence according to NP_001005388.2; NP_001153803.1; NP_001153804.1; NP_055905.2;. |
PBR (TSPO) (C-term) goat polyclonal antibody, Purified
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse |
| Immunogen | Synthetic peptide C-RDNSGRRGGSRLPE from the C-terminus of Mouse TSPO (NP_033905.3). Percent identity with other species by BLAST analysis: Mouse (100%), Rat (93%). C-Terminus |
Goat Polyclonal Anti-CD45 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 1,260 aa to the C-terminus of human CD45 produced in E. coli. |
Goat Anti-APOL1 Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-NNNYKILQADQE, from the C Terminus of the protein sequence according to NP_003652.2; NP_663318.1. |
Goat Polyclonal Anti-CD19 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 510 aa to the C-terminus of human CD19 produced in E. coli. |
Goat Polyclonal Anti-VEGFR2 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from the N-terminus (residues 20-125 aa) of human VEGFR2 produced in E. coli. |
PTCH1 (C-term) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IF, IHC |
| Reactivities | Human, Mouse, Rat |
| Immunogen | Peptide with sequence from the C Terminus of Human PTCH1 (NP_001077073.1, NP_001077074.1, NP_001077075.1, NP_001077076.1) |
Goat Polyclonal Anti-BDNF Antibody
| Applications | IF, IHC |
| Reactivities | Human, Mouse, Rat (Expected from sequence similarity: Dog) |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-BDNF Antibody: Peptide with sequence ETKCNPMGYTKE, from the internal region of the protein sequence according to NP_001700.2; NP_001700.2; NP_733928.1; NP_733929.1; NP_733930.1; NP_733931.1. |
Goat Anti-CACNA1C Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-RARGRPSEEELQD, from the C Terminus of the protein sequence according to NP_000710.5. |
Goat Polyclonal Anti-CD4 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within 50 to 235 aa, corresponding to the external domain of human CD4 produced in E. coli. |
Goat Polyclonal Antibody against ABCC8
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-EFDKPEKLLSRKD, from the C Terminus of the protein sequence according to NP_000343.2. |
Goat Polyclonal Anti-CDH1 (aa662-675) Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat, Pig (Expected from sequence similarity: Dog) |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-CDH1 (aa662-675) Antibody: Peptide with sequence C-DYKINLKLMDNQNK, from the internal region of the protein sequence according to NP_004351.1. |
Goat Polyclonal Anti-CD31 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 690 aa to the C-terminus of human CD31 produced in E. coli. |
Frizzled 2 (FZD2) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Immunogen | Peptide with sequence from the internal region of the protein sequence according to NP_001457.1. |
Goat Polyclonal Antibody against CADM4
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-KDERFQLEEFS, from the internal region of the protein sequence according to NP_660339.1. |
Goat Anti-CD20 / MS4A1 (C Terminus) Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence CQDQESSPIENDSSP, from the C Terminus of the protein sequence according to NP_068769.2; NP_690605.1. |
Goat Anti-GRIK3 / GLUR7 Antibody
| Applications | WB |
| Reactivities | Rat, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-KIRQLPIDSDDSRP, from the internal region of the protein sequence according to NP_000822.2. |
Goat Anti-Phospholamban / PLN Antibody
| Applications | WB |
| Reactivities | Human, Rat |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence KVQYLTRSAIRR-C, from the N Terminus of the protein sequence according to NP_002658.1. |
Goat Polyclonal Anti-CDH1 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified Recombinant peptide derived from within residues 601 to 701 of human CDH1 produced in E. coli. |
Goat Anti-ERN1 / IRE1a Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-PNAHGKIKAMISD, from the internal region of the protein sequence according to NP_001424.3. |
Goat Anti-SLC6A3 / DAT Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-QLTSSTLTNPRQSP, from the internal region (near N Terminus) of the protein sequence according to NP_001035.1. |
Goat Anti-NOX1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-DKATDIVTGLKQK, from the internal region of the protein sequence according to NP_008983.2; NP_39249.1. |
TGFBI Goat Polyclonal (Internal) Antibody
| Applications | IHC |
| Reactivities | Bat, Gibbon, Bovine, Dog, Gorilla, Horse, Human, Mouse, Pig, Rabbit, Rat |
| Conjugation | Unconjugated |
| Immunogen | TGFBI antibody was raised against synthetic peptide C-QLYTDRTEKLRPE from an internal region of human TGFBI (NP_000349.1). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Mouse, Rat, Elephant, Panda, Bovine, Dog, Bat, Horse, Rabbit, Pig, Opossum (100%); Marmoset, Platypus (92%). |
Goat Polyclonal Anti-ICAM1 (aa313-327) Antibody
| Applications | IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-ICAM1 (aa313-327) Antibody: Peptide with sequence C-PNVILTKPEVSEGTE, from the internal region of the protein sequence according to NP_000192.2. |
Goat Polyclonal Anti-CB1 (isoform a) Antibody
| Applications | WB |
| Reactivities | Human, Mouse (Expected from sequence similarity: Rat, Dog, Cow) |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-CB1 (isoform a) Antibody: Peptide with sequence SNDIQYEDIKGDMAS-C, from the N Terminus of the protein sequence according to NP_057167.2. |
Goat Polyclonal Antibody against Tafazzin
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-HLKTQAEQLHNH, from the C Terminus of the protein sequence according to NP_000107.1; NP_851828.1; NP_851829.1; NP_851830.1. |
Goat Polyclonal Antibody against NGFR
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-AKREEVEKLLNG, from the internal region of the protein sequence according to NP_002498.1. |
Goat Anti-P2RX7 / P2X7 receptor Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence YETNKVTRIQSMNY-C, from the N-Terminus of the protein sequence according to NP_002553.2. |
Active filters
Antibody Hosts
- Goat
Families
- Transmembrane
Filter by
Category
Target Symbol
- CANX (5)
- ALOX5AP (4)
- CADM4 (4)
- GJA1 (4)
- HP (4)
- ACPP (3)
- APOB (3)
- CDH1 (3)
- CDH11 (3)
- FGFR1 (3)
- GABRB3 (3)
- HRH1 (3)
- PNPLA2 (3)
- PTCH1 (3)
- SCARB2 (3)
- TNF (3)
- TSPO (3)
- ABCC4 (2)
- ACVR1 (2)
- ADAM12 (2)
- AMHR2 (2)
- ANPEP (2)
- ANTXR2 (2)
- APOL1 (2)
- ARL6IP5 (2)
- BDNF (2)
- CAV1 (2)
- CCL11 (2)
- CD14 (2)
- CD19 (2)
- CD4 (2)
- CD63 (2)
- CD74 (2)
- CHRNA7 (2)
- CLCN2 (2)
- CNR1 (2)
- COMT (2)
- COX4I1 (2)
- CPT1A (2)
- CPT1B (2)
- CYBB (2)
- CYP26A1 (2)
- DAGLA (2)
- DEFB4A (2)
- DUOX1 (2)
- ENPP1 (2)
- F2R (2)
- FCRL2 (2)
- FGG (2)
- FZD2 (2)
- FZD4 (2)
- GABRA4 (2)
- GCNT3 (2)
- GHRL (2)
- GRIA4 (2)
- GYPA (2)
- HTR3A (2)
- ICAM1 (2)
- KCNJ11 (2)
- KITLG (2)
- LEPR (2)
- MAOB (2)
- PPBP (2)
- PTPRC (2)
- ROR1 (2)
- SCD (2)
- SDF4 (2)
- SFRP1 (2)
- SIL1 (2)
- SLC25A47 (2)
- SLC46A1 (2)
- SLC47A2 (2)
- SRD5A1 (2)
- SRD5A2 (2)
- STX6 (2)
- SYVN1 (2)
- TGFBI (2)
- TMPRSS4 (2)
- TMX1 (2)
- TNFRSF13B (2)
- TNFRSF9 (2)
- TNFSF11 (2)
- TNFSF12 (2)
- TNFSF13B (2)
- WNT3 (2)
- WNT9B (2)
- A4GNT (1)
- ABCA9 (1)
- ABCB5 (1)
- ABCB9 (1)
- ABCC1 (1)
- ABCC11 (1)
- ABCC5 (1)
- ABCC8 (1)
- ABCD3 (1)
- ABCD4 (1)
- ABHD12 (1)
- ACACB (1)
- ACKR1 (1)
- ACSL4 (1)
Reactivities
Isotypes
Clonalities
Conjugates
Pathways
- Neuroactive ligand-receptor interaction (70)
- Cytokine-cytokine receptor interaction (51)
- Calcium signaling pathway (36)
- Metabolic pathways (35)
- Pathways in cancer (33)
- Cell adhesion molecules (CAMs) (28)
- Hematopoietic cell lineage (28)
- MAPK signaling pathway (19)
- Regulation of actin cytoskeleton (17)
- Wnt signaling pathway (16)
- Basal cell carcinoma (15)
- Adipocytokine signaling pathway (14)
- Alzheimer's disease (14)
- Endocytosis (14)
- Melanogenesis (14)
- Natural killer cell mediated cytotoxicity (14)
- Leukocyte transendothelial migration (13)
- T cell receptor signaling pathway (13)
- ABC transporters (12)
- Antigen processing and presentation (11)
- Chemokine signaling pathway (11)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (10)
- Dilated cardiomyopathy (10)
- Focal adhesion (10)
- Primary immunodeficiency (10)
- Prostate cancer (10)
- TGF-beta signaling pathway (10)
- Viral myocarditis (10)
- Adherens junction (9)
- Apoptosis (9)
- Colorectal cancer (9)
- Gap junction (9)
- Hedgehog signaling pathway (9)
- Melanoma (9)
- PPAR signaling pathway (9)
- Type II diabetes mellitus (9)
- Vascular smooth muscle contraction (9)
- Axon guidance (8)
- Fatty acid metabolism (8)
- Huntington's disease (8)
- Hypertrophic cardiomyopathy (HCM) (8)
- Toll-like receptor signaling pathway (8)
- Allograft rejection (7)
- Amyotrophic lateral sclerosis (ALS) (7)
- Androgen and estrogen metabolism (7)
- Asthma (7)
- Jak-STAT signaling pathway (7)
- Neurotrophin signaling pathway (7)
- Type I diabetes mellitus (7)
- Bladder cancer (6)
- Endometrial cancer (6)
- Fc epsilon RI signaling pathway (6)
- Graft-versus-host disease (6)
- Lysosome (6)
- Parkinson's disease (6)
- Retinol metabolism (6)
- Systemic lupus erythematosus (6)
- Tyrosine metabolism (6)
- Autoimmune thyroid disease (5)
- Cardiac muscle contraction (5)
- Complement and coagulation cascades (5)
- Epithelial cell signaling in Helicobacter pylori infection (5)
- ErbB signaling pathway (5)
- GnRH signaling pathway (5)
- NOD-like receptor signaling pathway (5)
- Notch signaling pathway (5)
- Pathogenic Escherichia coli infection (5)
- Riboflavin metabolism (5)
- ECM-receptor interaction (4)
- Fc gamma R-mediated phagocytosis (4)
- Long-term depression (4)
- Oxidative phosphorylation (4)
- RIG-I-like receptor signaling pathway (4)
- Renin-angiotensin system (4)
- SNARE interactions in vesicular transport (4)
- Tryptophan metabolism (4)
- Arachidonic acid metabolism (3)
- Arginine and proline metabolism (3)
- B cell receptor signaling pathway (3)
- Biosynthesis of unsaturated fatty acids (3)
- Drug metabolism - cytochrome P450 (3)
- Glycerolipid metabolism (3)
- Glycine (3)
- Histidine metabolism (3)
- Long-term potentiation (3)
- N-Glycan biosynthesis (3)
- Nicotinate and nicotinamide metabolism (3)
- Non-small cell lung cancer (3)
- Pancreatic cancer (3)
- Phenylalanine metabolism (3)
- Propanoate metabolism (3)
- Thyroid cancer (3)
- Tight junction (3)
- Vibrio cholerae infection (3)
- serine and threonine metabolism (3)
- C21-Steroid hormone metabolism (2)
- Ether lipid metabolism (2)
- Glioma (2)
- Glutathione metabolism (2)
- Glycerophospholipid metabolism (2)
- Insulin signaling pathway (2)
- Linoleic acid metabolism (2)
- Metabolism of xenobiotics by cytochrome P450 (2)
- O-Glycan biosynthesis (2)
- Pantothenate and CoA biosynthesis (2)
- Prion diseases (2)
- Purine metabolism (2)
- Pyruvate metabolism (2)
- Starch and sucrose metabolism (2)
- Taste transduction (2)
- Ubiquitin mediated proteolysis (2)
- VEGF signaling pathway (2)
- Valine (2)
- beta-Alanine metabolism (2)
- leucine and isoleucine degradation (2)
- p53 signaling pathway (2)
- Acute myeloid leukemia (1)
- Amino sugar and nucleotide sugar metabolism (1)
- Ascorbate and aldarate metabolism (1)
- Base excision repair (1)
- Butanoate metabolism (1)
- Dorso-ventral axis formation (1)
- Fatty acid biosynthesis (1)
- Glycolysis / Gluconeogenesis (1)
- Glycosphingolipid biosynthesis - lacto and neolacto series (1)
- Inositol phosphate metabolism (1)
- Keratan sulfate biosynthesis (1)
- Limonene and pinene degradation (1)
- Lysine degradation (1)
- Maturity onset diabetes of the young (1)
- Nitrogen metabolism (1)
- Oocyte meiosis (1)
- Phosphatidylinositol signaling system (1)
- Porphyrin and chlorophyll metabolism (1)
- Primary bile acid biosynthesis (1)
- Small cell lung cancer (1)
- Sphingolipid metabolism (1)
- alpha-Linolenic acid metabolism (1)